Moving toward an understanding of the metastatic process in hepatocellular carcinoma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Can heme oxygenase-1 be a prognostic factor in patients with hepatocellular carcinoma?Medicine · 2019
   Article
2. Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.World journal of gastroenterology · 2014
   Review
3. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients.ISRN hepatology · 2013
   Article
4. Micronutrient Synergy in the Fight against Hepatocellular Carcinoma.Cancers · 2012
   Article
5. Biomarkers for hepatocellular carcinoma.International journal of hepatology · 2012
   Article
6. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.BMC cancer · 2006
   Article
7. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma.World journal of gastroenterology · 2004
   Article
8. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.Journal of cancer research and clinical oncology · 2004
   Review
9. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma.World journal of gastroenterology · 2004
   Article
10. Experimental study of anti-tumor effects of polysaccharides from Angelica sinensis.World journal of gastroenterology · 2003
    Article
11. Expression and significance of RhoC gene in hepatocellular carcinoma.World journal of gastroenterology · 2003
    Article
12. Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer.World journal of gastroenterology · 2003
    Article
13. The prognostic molecular markers in hepatocellular carcinoma.World journal of gastroenterology · 2002
    Review
14. Pigment epithelium-derived factor and matrix metalloproteinase-9 in liver cirrhosis.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Article

Corrections and comments

• Comment on
  Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.2001

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as